Rega marang bathi mangsa ngarep: PepGen (PEPG)
PepGen Inc. possesses high potential due to its proprietary peptide delivery system, which ensures monopoly status. The company's forward P/E ratio demonstrates valuation dynamics, where the value 0.00 represents the current metric. The business relies on the diversification of clinical programs for the treatment of neuropathies. Meanwhile, massive R&D expenditures for oligonucleotide drugs keep the operating leverage in negative territory.
PepGen Corp (PEPG) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- data ekuitas miturut neraca:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas PepGen Inc.|PEPG - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas PepGen Inc.|PEPG - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku PepGen Inc|PEPG - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan PepGen|Rasio cepet pepgen.com
- statistik bathi lan rasio pasar:
PEPG - Penghasilan resik|Bathi mangsa ngarep PepGen Inc.|PEPG - Periode bali modal bisnis|Rega marang bathi mangsa ngarep PepGen Inc.|PEPG - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA PepGen Inc|PEPG - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan PepGen|PEPG - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan pepgen.com|PEPG - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PepGen Inc.
Pambiji fundamental:PepGen
PepGen Inc. is developing a biopharmaceutical platform through strategic partnerships with industry behemoths, as it lacks its own funds for mergers. By analyzing the company's forward P/E ratio, an investor assesses the current share price relative to the projected net income for the coming year, which helps determine the extent of the asset's premium and minimizes the risk of investing in an overvalued instrument.
Pesaing utama
Pangali Forward P/E BIIB|NBIX - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Regencell RGC|AXSM (Axsome Corp) - Rasio rega marang bathi sing dikarepake|ACADIA Pharmaceuticals - Pangali Forward P/E|Pangali forward rega marang bathi xenon-pharma.com (XENE)|VKTX: Pangali Forward P/E|Rasio prakiraan rega marang bathi Supernus Pharmaceuticals, Inc. (SUPN)|Rega marang bathi mangsa ngarep Catalyst Pharmaceuticals Inc|Rasio rega marang bathi mangsa ngarep DNLI (Denali Corp)|Prakiraan rega marang bathi HRMY (Harmony Biosciences)|BHVN (biohavenpharma.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMLX (Amylyx Pharmaceuticals, Inc.)|Kapitalisasi marang proyeksi bathi Trevi Therapeutics Inc (TRVI)|PRAX - Rega marang bathi mangsa ngarep|AVXL (Anavex Life Sciences Corp) - Rasio rega marang bathi mangsa ngarep|CBLL: Pangali Forward P/E|Prakiraan rega marang bathi Prothena|Prakiraan rega marang bathi ALEC|Annexon Biosciences (ANNX) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|NGNE: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E ACIU (AC Immune)|voyagertherapeutics.com (VYGR) - Rasio prakiraan rega marang bathi|NMRA - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake SCLX|TVGN: Pangali Forward P/E|Pangali forward rega marang bathi Alpha Cognition Inc. ACOG|Rega marang bathi mangsa ngarep Cognition Therapeutics|Rasio rega marang bathi mangsa ngarep IKT (inhibikase.com)|Pangali Forward P/E SAVA|ASRT - Rasio prakiraan rega marang bathi|Coya Therapeutics - Prakiraan rega marang bathi|Pangali Forward P/E VistaGen Therapeutics, Inc. VTGN|OVID - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi ABOS (acumenpharm.com)|CervoMed (CRVO) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Alterity Therapeutics Limited (ATHE)|Rega marang bathi mangsa ngarep Clene Inc|Jupiter Neurosciences, Inc. - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E RLMD|ANVS - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Grace Therapeutics GRCE|AIFF (Firefly Neuroscience, Inc.) - Rasio rega marang bathi sing dikarepake|ANEW Medical, Inc. - Pangali Forward P/E|Pangali forward rega marang bathi NeuroSense Therapeutics (NRSN)|RVPH: Pangali Forward P/E|Rasio prakiraan rega marang bathi MetaVia (MTVA)|Rega marang bathi mangsa ngarep NeurAxis|Rasio rega marang bathi mangsa ngarep HSDT (Helius Medical Technologies Inc.)|Prakiraan rega marang bathi PASG (Passage Bio, Inc.)|NEUP (bionomics.com.au) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E NERV (Minerva Neurosciences)|Kapitalisasi marang proyeksi bathi athira.com (ATHA)|ADXN - Rega marang bathi mangsa ngarep|ALZN (Alzamend Neuro, Inc.) - Rasio rega marang bathi mangsa ngarep|CYCN: Pangali Forward P/E|Prakiraan rega marang bathi Protagenic Therapeutics, Inc.|Prakiraan rega marang bathi KTTA|Cortigent Medical (CRGT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Avenue Therapeutics, Inc. (ATXI)|BCLI: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E CARA (Cara Therapeutics, Inc)|Chromocell (CHRO) - Rasio prakiraan rega marang bathi|ELYM - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake ITCI|LBPH: Pangali Forward P/E|Pangali forward rega marang bathi Marinus Pharmaceuticals Inc MRNS|Rega marang bathi mangsa ngarep NKGen|Rasio rega marang bathi mangsa ngarep NRBO (NeuroBo Pharma)|Pangali Forward P/E SAGE|SNPX - Rasio prakiraan rega marang bathi|Trevena - Prakiraan rega marang bathi|Pangali Forward P/E Vigil Neuroscience Inc. VIGL|WENA - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi CERE (Cerevel Corp)
